|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03689 KANGHUA HEALTH
Nominal 
2.270 +0.410 (+22.043%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 2,041,858 | 10.632% | 1,845,633 | 1,953,944 | 1,745,023 | 1,955,525 |
| Cost of Sales | (1,677,488) | 5.883% | (1,584,283) | (1,601,196) | (1,481,868) | (1,566,106) |
| Gross Profit | 364,370 | 39.418% | 261,350 | 352,748 | 263,155 | 389,419 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,768) | -34.252% | (4,210) | (18,443) | (75,553) | (60,596) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 153,429 | 121.370% | 69,309 | 129,209 | (26,089) | 117,485 | |
| Taxation | (62,406) | 45.046% | (43,025) | (62,284) | (23,967) | (68,797) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 30,039 | -10.098% | 33,413 | 27,382 | 24,684 | 25,576 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 121,062 | 102.794% | 59,697 | 94,307 | (25,372) | 74,264 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 7,137 | -39.604% | 11,817 | 17,943 | 17,957 | 14,452 |
| Depreciation & Amortisation | 143,079 | -4.257% | 149,441 | 149,443 | 142,888 | 122,604 |
| Directors' Emoluments | 2,493 | -19.658% | 3,103 | 3,040 | 3,068 | 3,910 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 36.200 | 102.235% | 17.900 | 28.200 | -7.600 | 22.200 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.611 | -- | 0.662 | 0.997 | 0.823 | 0.294 |
| NBV per share ($) | 4.259 | -- | 4.483 | 4.267 | 3.985 | 4.056 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -19,542,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.058 |
| NBV Per Share (¥) | RMB 4.201 |